Valley Drug Co. v. Geneva Pharmaceuticals, Inc.: Enlarging the Patent Exclusionary Right Through Hatch-Waxman Settlement Agreements Is Not Per Se Anticompetitive?

Authors

  • Stephen Roy Jenkins

Downloads

Published

2019-08-27

Issue

Section

Articles